drugset / Trial / NCT05303818

Chemoprophylaxis With Rivaroxaban for Lower Limb Deep Vein Thrombosis in Colorectal Cancer

NCT05303818

Phase 4 Unknown 68 enrolled Hospital do Servidor Publico Estadual
NaSingle-groupOpen-labelPrevention

Summary

The chemoprophylaxis of deep vein thrombosis (DVT) with subcutaneous low-molecular-weight heparin (enoxaparin) in the postoperative period of elective surgeries is already well established in the literature and in clinical practice. However, the use of this medication can have a financial impact on the patient and the parenteral presentation itself is associated with pain at the application site, which can make it difficult for patients to adhere.

Timeline

Start
2022-06-01
Primary completion
2023-06-01
Completion
2024-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Rivaroxaban Other / unclassified 10 mg Oral